Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
198 studies found for:    "Aplastic anemia"
Show Display Options
RSS Create an RSS feed from your search for:
"Aplastic anemia"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Eltrombopag for Moderate Aplastic Anemia
Conditions: Eltrombopag;   Aplastic Anemia;   Aplastic Anemia Treatment;   Moderate Aplastic Anemia;   Moderate Aplastic Anemia Treatment;   Unilineage Bone Marrow Failure Disorders
Intervention: Drug: Eltrombopag
2 Active, not recruiting Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia;   Very Severe Aplastic Anemia;   Moderate Aplastic Anemia
Intervention: Drug: Eltrombopag
3 Completed
Has Results
Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Neutropenia;   Pancytopenia;   Severe Aplastic Anemia
Interventions: Drug: Cyclophosphamide;   Drug: Cyclosporine
4 Completed
Has Results
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Neutropenia;   Pancytopenia;   Severe Aplastic Anemia
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine
5 Active, not recruiting Alemtuzumab to Treat Severe Aplastic Anemia
Conditions: Relapsed or Refractory Severe Aplastic Anemia;   Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath )
6 Recruiting NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia
Conditions: Severe Aplastic Anemia;   Aplastic Anemia;   Bone Marrow Failure;   Immunosuppression
Interventions: Drug: Thymoglobulin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total body irradiation;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil
7 Suspended Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alefacept
8 Completed Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
9 Withdrawn Alemtuzumab and Rituximab in Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: Alemtuzumab and Rituximab
10 Unknown  Moderate-dose Cyclophosphamide for Childhood Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Drug: cyclophosphamide,cyclosporine A
11 Completed Stem Cell Factor Medication for Aplastic Anemia
Conditions: Aplastic Anemia;   Pancytopenia
Intervention: Drug: Recombinant Methionyl Human Stem Cell Factor (r-metHuSCF)
12 Recruiting Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Romiplostim
13 Completed Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
Condition: Aplastic Anemia
Intervention:
14 Completed Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
Condition: Aplastic Anemia
Intervention: Biological: Intravenous bone marrow mesenchymal stem cells infusion
15 Recruiting Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
Conditions: Dyskeratosis Congenita;   Aplastic Anemia
Interventions: Drug: Alemtuzumab;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation;   Biological: Stem Cell Transplant;   Drug: Anti-thymocyte globulin
16 Completed
Has Results
Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Antithymocyte Globulin
17 Completed Comparing Therapies for the Treatment of Severe Aplastic Anemia
Conditions: Aplastic Anemia;   Hematologic Disease
Interventions: Drug: Antithymocyte globulin & Cyclosporin A;   Drug: Cyclophosphamide & Cyclosporin A
18 Completed Mycophenolate Mofetil and Cyclosporine to Treat Relapsing Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Mycophenolate mofetil;   Drug: Cyclosporine
19 Terminated
Has Results
Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Cytoxan;   Drug: Campath;   Radiation: Total Body Irradiation (TBI);   Drug: FK-506;   Drug: Methotrexate;   Procedure: Stem cell infusion
20 Active, not recruiting Fludarabine-Based Conditioning for Allogeneic Marrow Transplantation in Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Antithymocyte Globulin;   Drug: Cyclophosphamide;   Drug: Fludarabine;   Radiation: Total Body Irradiation (TBI);   Procedure: Bone Marrow Transplant

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years